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Background/Aims. The effects of cholecalciferol supplementation on the course of diabetes in humans and animals need to be
better understood. Therefore, this study investigated the effect of short-term cholecalciferol supplementation on biochemical and
hematological parameters inmice.Methods.Male diabetic (alloxan, 60mg/kg i.v., 10 days) and nondiabeticmicewere supplemented
with cholecalciferol for seven days.The following parameters were determined: serum levels of 25-hydroxyvitamin D, phosphorus,
calcium, urea, creatinine, alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, red blood cell count,
white blood cell count (WBC), hematocrit, hemoglobin, differential cell counts of peritoneal lavage (PeL), and bronchoalveolar
lavage (BAL) fluids and morphological analysis of lung, kidney, and liver tissues. Results. Relative to controls, cholecalciferol
supplementation increased serum levels of 25-hydroxyvitamin D, calcium, hemoglobin, hematocrit, and red blood cell counts and
decreased leukocyte cell counts of PeL and BAL fluids in diabetic mice. Diabetic mice that were not treated with cholecalciferol had
lower serum calcium and albumin levels and hemoglobin, WBC, and mononuclear blood cell counts and higher serum creatinine
and urea levels than controls. Conclusion. Our results suggest that cholecalciferol supplementation improves the hematological
parameters and reduces leukocyte migration into the PeL and BAL lavage of diabetic mice.
1. Introduction
Type 1 diabetes mellitus (T1D) is an autoimmune disorder
that causes destruction of pancreatic 𝛽 cells and insulitis
resulting in loss of insulin secretion [1].
Several studies have demonstrated that diabetic individu-
als with uncontrolled hyperglycemia may experience weight
loss, uncontrolled immune response, hematological alter-
ations, and lung, liver, and kidney injuries [2, 3]. In addition,
renal impairment in diabetes may affect the metabolism of
urea, creatinine [4], hemoglobin (Hb) [5], albumin [6], and
vitamin D [7, 8].
Anemia is defined as a decrease in the amount
of hemoglobin (Hb) or the number of red blood cells
(RBC) in the blood. It is a common complication in patients
with diabetic kidney disease and it increases mortality in
diabetic individuals, but its mechanism of action is still not
clear [9].
Albumin is the major plasma protein and plays a critical
role in maintaining tissue oncotic pressure and in the trans-
port of substances such as vitamin D into the bloodstream.
Studies have suggested that hepatic albumin synthesis and
secretion are reduced in diabetic rats [10].
Vitamin D is a hormone obtained from the diet and/or
by endogenous synthesis. The vitamin Dmolecule is hydrox-
ylated twice, once in the liver by the enzyme 25–hydroxylase
and once in the kidney by the enzyme 1𝛼–hydroxylase, to
form calcitriol (1,25(OH)2D), which is the form of vitamin
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D that interacts with vitamin D receptor (VDR) to perform
its biological activity [7].
The classic activity of calcitriol is to regulate bone
metabolism by maintaining a balance between calcium (Ca)
and phosphorus (P) concentrations [8]. Studies have reported
that vitaminDmay affect the course of T1D by immunomod-
ulation [11]. Although the mechanism of action is still
unknown, serum 1,25(OH)2D levels appear to modulate the
level of systemic cytokine production and to increase white
blood cell (WBC) count [12, 13].
Although vitamin D supplementation is an important
aid in clinical practice, few studies have demonstrated the
effects of vitamin D supplementation on the course of T1D
in humans and animals. In addition, vitamin D supple-
mentation studies are often contradictory due to the lack
of precise information on regimen and dosage protocols
[14].
Thus, using a well-established mouse model of T1D,
we investigated the effect of vitamin D supplementation
on histological, biochemical, and hematological parameters
and on bronchoalveolar lavage (BAL) and peritoneal lavage
(PeL) fluids in male (C57BL/6) diabetic and nondiabetic
mice. The hypothesis is that vitamin D supplementation
improves the hematological parameters and reduces inflam-
matory cell migration into the PeL and BAL fluid of diabetic
mice.
2. Materials and Methods
2.1. Animals. Thirty-one specific pathogen-free male
C57BL/6 mice weighing 25 ± 2 g at baseline were used. The
animals were maintained at 22∘C under a 12 h light-dark
cycle. Food and water were provided ad libitum before and
during the experimental period. This study was conducted
in strict accordance with the principles and guidelines of the
National Council for the Control of Animal Experimentation
(CONCEA) and approved by the Ethics Committee on
Animal Use (CEUA) at the School of Pharmaceutical
Sciences (FCF), University of Sa˜o Paulo, Brazil (protocol
number: CEUA/FCF/389). Surgery was performed under
ketamine/xylazine anesthesia and all efforts were made to
minimize animal suffering.
2.2. Induction of Diabetes Mellitus. Animals were sepa-
rated in four groups: control (C), control supplemented
with vitamin D (CV), diabetic (D), and diabetic supple-
mented with vitamin D (DV). Briefly, diabetes mellitus
was induced by intravenous injection of 60mg/kg alloxan
monohydrate (ALX) (Sigma Chemical Co., St. Louis, MO,
USA) dissolved in physiological saline (0.9% NaCl). Control
mice were injected with physiological saline only. Ten days
after diabetes induction, body weight was measured and
peripheral blood (tail vein) glucose level was determined
using an Accu-Chek Advantage II blood glucose monitor
(Roche Diagno´stica, Sa˜o Paulo, SP, Brazil). Animals were
considered diabetic if glucose level was above 300mg/dL
[15].
2.3. Vitamin D Supplementation. Animals in the CV and
DV groups were supplemented orally with 800 IU of vitamin
D (Sanofi Aventis, Sa˜o Paulo, SP, Brazil) for seven days
[14]. The last dose of vitamin D was administered 24 h
before the experiment to minimize stress-induced endocrine
changes caused by oral administration of the hormone
[16]. Body weight and blood glucose were measured on
the first, fourth, and seventh day of the supplementation
period.
2.4. Blood Collection. Animals were anesthetized by an
intraperitoneal injection of 10mg/kg xylazine hydrochloride
(Ceva Sante´ Animale, Paul´ınia, SP, Brazil) and 90mg/kg
ketamine hydrochloride (Ceva Sante´ Animale). Blood was
collected from anesthetized animals by cardiac puncture.
Samples of EDTA-anticoagulated blood were used to deter-
mine the following hematological parameters: red blood
cell (RBC) count, white blood cell (WBC) count, hemat-
ocrit (Htc), and hemoglobin (Hb). All analyses were per-
formed using a veterinary hematology analyser ABC Vet
(HORIBA, UK). Differential cell counts were determined
on stained slides under oil immersion microscopy. Based on
morphological criteria, 100 cells per sample were counted
and classified as either mononuclear or polymorphonuclear.
A sample aliquot without anticoagulant was centrifuged
(10min, 3500 rpm) at room temperature. Next, the serumwas
separated and used for measuring ionic calcium (Ca), phos-
phorus (P), albumin, alanine transaminase (ALT), aspartate
aminotransferase (AST), alkaline phosphatase (ALP), urea,
and creatinine by colorimetric assay according to the man-
ufacturer’s protocol (LabTest Diagno´stica, Lagoa Santa, MG,
Brazil). Serum 25(OH)D was measured by EUROIMMUN
25–OH–Vitamin D ELISA kit (Luebeck, Germany). Serum
samples were stored at −80∘C.
2.5. Peritoneal and Bronchoalveolar Lavage. The abdomen
of all mice was exposed through a ventral midline incision.
Peritoneal lavage (PeL)was performedby instillation of 10mL
(two 5mL infusions) of phosphate buffered saline (PBS;
137mM NaCl, 2.7mM KCl, 4.3mM Na2HPO4, and 1.47mM
KH2PO4; pH 7.4) at room temperature [17]. The trachea
was exposed through a midline ventral incision in the neck.
Bronchoalveolar lavage (BAL) was performed by instillation
of 5mL (five 1mL infusions) of PBS at room temperature
through a 16G × 1.88󸀠󸀠 BD Angiocath polyethylene tube
(BD, Franklin Lakes, NJ, USA) inserted into the trachea.
Next, PeL and BAL samples were centrifuged (1500 rpm,
10min, 4∘C), supernatants were discarded, and the cells
were resuspended in PBS (1mL). The cell suspension was
diluted 1 : 2 (v : v) with Turk’s solution. Total cell counts were
determined using a Neubauer chamber and differential cell
counts were examined on stained slides under oil immersion
microscopy. A total of 100 cells were counted and classified
as neutrophils, lymphocytes, or macrophages based on mor-
phological criteria.
2.6. Tissue Extraction andHistological Analysis. Kidney, liver,
and lung samples were extracted and subsequently fixed
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in formaldehyde solution (10%). After fixation, tissues were
dehydrated in increasing ethanol concentrations (70–100%),
diaphonized in xylol, and embedded in paraffin. Transverse
sections (5 𝜇m) obtained after inclusion were stained with
hematoxylin and eosin (H/E). After staining, the material
was dehydrated, diaphonized, and mounted with Entellan.
Slides containing the tissue were observed under a light
microscope (Nikon Eclipse 80i, Tokyo, Japan) and pho-
tographed using the NIS-Elements AR imaging software
(Nikon).
2.7. Data and Statistical Analysis. The data were analysed
by analysis of variance (ANOVA) followed by the Tukey-
Kramer multiple comparisons test (when appropriate) or
unpaired 𝑡-test using GraphPad Prism 6.0 software (La
Jolla, CA, USA). A two-tailed 𝑝 value with 95% confidence
interval was computed. Data are presented as mean ± stan-
dard deviation (SD). Data were considered significant when
𝑝 < 0.05.
3. Results
3.1. Body Weight Gain and Blood Glucose Levels. Ten days
after administration of ALX, diabetic mice exhibited sharply
elevated blood glucose (mean ± SD; control, 165.6 ±
5.7mg/dL, 𝑛 = 18; diabetic, 568.1 ± 10.0mg/dL, 𝑛 = 13; 𝑝 <
0.001) levels and a reduction in body weight gain (control,
0.8 ± 0.3 g, 𝑛 = 18; diabetic, −1.3 ± 0.4 g, 𝑛 = 13; 𝑝 < 0.05)
compared to controls.
3.2. Analysis of Vitamin D Supplementation. Animals supple-
mented with cholecalciferol (CV and DV groups) exhibited
higher serum 25(OH)2D (ng/mL) levels than their respective
controls (C andD groups).These results indicate that vitamin
D supplementation was successful (Figure 1(a)).
Diabetic mice had lower serum Ca (mg/dL) levels than
nondiabetic animals. However, vitamin D supplementation
restored serum Ca levels in the DV group (Figure 1(b)).
Serum phosphorus (mg/dL) levels were significantly
higher in vitamin D-treated nondiabetic mice compared to
nondiabetic controls (Figure 1(c)).
3.3. Temporal Variation of Blood Glucose Levels and Body
Weight. Body weight gain and blood glucose levels were
measured during the supplementation period. Body weight
wasmeasured in the first and seventh days of the experiment.
There was no significant difference in body weight variation
between vitamin D3-supplemented animals (CV, 0.1 ± 0.3 g,
𝑛 = 9; DV, −1.3 ± 1.0 g, 𝑛 = 7) and their respective controls
(C, 0.3 ± 0.3 g, 𝑛 = 9; D, −1.1 ± 0.9 g, 𝑛 = 6). Blood
glucose was measured on the first, fourth, and seventh
day of the experimental period (Figure 1(j)). There was no
significant difference in glycemic evolution between vitamin
D3-supplemented (CV and DV) groups and controls (C
and D groups). However, blood glucose levels remained
significantly higher in diabetic mice (D and DV groups) than
in controls (C and CV).
3.4. Vitamin D3 Supplementation Improved Hematological
Parameters. Diabetic mice had lower RBC, Hb, Htc, WBC,
and peripheral blood mononuclear cell counts than controls
(Figure 2). Diabetic mice supplemented with vitamin D3
had higher RBC, Hb, Htc, WBC, and mononuclear cell
counts than diabetic mice. In addition, diabetic mice sup-
plemented with vitamin D3 had higher Hb and hematocrit
levels than nondiabetic mice supplemented with vitamin D3
(Figure 2).
3.5. Vitamin D3 Supplementation in the Kidneys and Liver.
Diabetic mice had significantly higher serum levels of urea
(Figure 1(d)) and creatinine than controls (Figure 1(e)). In
addition, diabetic mice had a significant reduction in serum
albumin concentration compared to controls (Figure 1(f)).
However, there were no significant differences in serum levels
ofALP,AST, andALT (Figures 1(g)–1(i)) between vitaminD3-
treated mice and their respective controls. Compared to con-
trols, diabetic mice exhibited a thickening of the Bowman’s
capsule. However, vitaminD supplementation did not restore
this renal parameter (Figure 3). No significant differences
in liver (Figure 4) and lung (Figure 5) morphology were
observed between vitamin D3-supplemented animals (CV
and DV) and their respective controls.
3.6. Cell Composition of Bronchoalveolar Lavage and Peritone-
al Lavage Fluids. The PeL fluid of vitamin D3-supplemented
mice had 4.9-fold more neutrophils than respective controls,
but no significant difference in total cell counts was observed
across groups. Total leukocyte counts in the PeL fluid were
reduced by 47% in vitamin D3-treated diabetic mice com-
paredwith diabeticmice. Similarly, a 5.7-fold decrease in total
leukocyte count was observed in the BAL fluid of vitaminD3-
treated diabetic mice (Table 1).
4. Discussion
Alloxan (ALX) is an effective diabetes-inducing agent widely
used in experimental animal models. ALX administration
produces hyperglycemia, which leads to polyuria and weight
loss [18]. In our study, blood glucose and body weight were
measured 10 days after ALX administration. During the
experimental period, diabetic mice exhibited lower body
weight gain and hyperglycemia than nondiabetic mice.
Both metabolic alterations may occur due to increased
lipolysis and oxidative degradation of amino acids that
increase tissue energy expenditure and body weight loss
[19].
Few studies have demonstrated the effects of vitamin D3
supplementation on T1D in animal models. Nevertheless,
results are controversial due to the use of different animal
strains, protocols, doses, periods, and routes of supplemen-
tation. In our study, diabetic and nondiabetic mice sup-
plemented with 800 IU (40000 IU/kg body weight/day) of
vitamin D3 had higher serum 25(OH)2D levels than controls.
According to Takiishi et al. (2014), this dose causes no
significant alterations in serum P or Ca levels in nonobese
diabetic (NOD) mice [14].
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Figure 1: Continued.
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Figure 1: Biochemical and vitamin D levels. Data are expressed as mean and standard deviation for 3–9 animals per group. #𝑝 < 0.05;
e𝑝 < 0,01; and ∗𝑝 > 0.001. 25(OH)D: 25-hydroxyvitamin D; ALP: alkaline phosphatase; ALT: alanine transaminase; AST: aspartate
aminotransferase; C: control; CV: vitamin D; D: diabetic; DV: diabetic + vitamin D.
Table 1: Quantification of pulmonary and peritoneal leukocytes.
White cells (105 cells/mL)
Site Group 𝑁 Total Macrophage Lymphocyte Neutrophil
Peritoneum
Control 9 11.2 ± 2.8 8.1 ± 2.3 2.95 ± 0.0 0.1 ± 0.0
Vitamin D 7 16.0 ± 3.2 12.0 ± 2.2 3.4 ± 1.5 0.5 ± 0.1∗
Diabetic 7 18.7 ± 3.0 14.8 ± 3.2 3.6 ± 0.8 0.2 ± 0.1
Diabetic + vitamin D 7 8.8 ± 2.1# 7.6 ± 1.7 1.0 ± 0.5 0.3 ± 0.2
Lung
Control 3 4.6 ± 2.0 3.5 ± 1.9 0.9 ± 0.6 0.2 ± 0.1
Vitamin D 4 9.1 ± 4.0 6.8 ± 2.4 2.0 ± 1.5 0.3 ± 0.2
Diabetic 3 14.5 ± 4.0 11.5 ± 2.1 2.5 ± 1.4 0.9 ± 0.6
Diabetic + vitamin D 3 2.1 ± 0.7# 19.9 ± 0.5 0.1 ± 0.1 0.1 ± 0.0
Mice were rendered diabetic by the injection of alloxan (60mg/kg, i.v.), 10 days before vitamin D supplementation (800 IU/day, o.v.). BAL and PeL were
performed 24 h thereafter. Values are expressed as means ± SD.
∗𝑝 < 0.01 versus corresponding values in control group.
#𝑝 < 0.05 versus corresponding values in diabetic group.
The role of vitamin D3 in body weight control is con-
troversial. The presence of 1𝛼–hydroxylase and VDR in
adipose tissue cells suggests the involvement of vitamin D in
body weight regulation [20]. Weight loss has been associated
with Ca metabolism, which is regulated by Vitamin D3.
The increase in Ca availability enhances oxidation, promotes
apoptosis of adipocytes, and reduces the absorption of lipids
due to the formation of insoluble molecules in the intestine
[21]. However, Takiishi et al. found no difference in body
weight variation between vitamin D3-treated NODmice and
controls [14]. Similarly, in our study, there was no significant
difference in body weight variation between vitamin D3-
treatedmice and controls during the supplementation period.
The effects of vitamin D3 supplementation on glycemic
control in animal models are controversial. Relative to
controls, NOD mice treated with high doses of calcitriol
(5 𝜇g/kg/alternate days) showed lower insulitis and a reduc-
tion in T cell counts [22]. However, vitamin D supple-
mentation had little effect in reverting overt diabetes in
streptozotocin-induced diabetic mice [23]. In the current
study, vitamin D supplementation did not reduce blood
glucose levels in diabetic mice compared to controls.
Themajor role of vitaminD3 in the body is to regulate the
concentrations of Ca and P [8]. Few studies have focused on
how vitamin D and its analogues may affect Ca homeostasis
in T1D [24, 25]. In addition, diabetic individuals can exhibit
low serum Ca and P levels due to renal disorders [26]. In
the current study, serum concentrations of these ions were
measured. Diabetic mice had lower serum Ca levels than
controls and vitamin D3 supplementation increased these
levels in the former. High 1,25(OH)2D levels stimulate bone
turnover, renal excretion, and intestinal Ca absorption [7].
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Figure 2:Hematological parameters. Data are expressed asmean and standard deviation for 3–9 animals per group. #𝑝 < 0.05 and ∗𝑝 > 0.001.
C: control; CV: vitamin D; D: diabetic; DV: diabetic + vitamin D.
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Figure 3: Renal tissue of mice. Photomicrograph of the mice kidney tissue. C1, C2, and C3 renal tissue of animal control; CV1, CV2, and
CV3 renal tissue of animal supplemented with vitamin D; D1, D2, and D3 renal tissue of diabetic animal; DV1, DV2, and DV3 renal tissue of
diabetic animal supplemented with vitamin D. Diabetic animals presented thickening of Bowman’s capsule (C). Presence of glomerulus (G)
(bars, C1, CV1, D1, and DV1 = 100 𝜇m; C2, CV2, D2, and DV2 = 50 𝜇m; C3, CV3, D3, and DV3 = 10 𝜇m). Staining: H/E.
However, serum P levels in our study were significantly
higher in vitamin D3-treated nondiabetic mice than controls.
There was no significant difference in P levels between
vitamin D3-treated and control diabetic mice.
Vitamin D is transported by albumin and vitamin D-
binding protein in the bloodstream to the liver and kidneys,
where it is activated [7, 8]. In the current study, liver enzymes
(ALP, ALT, and AST) were measured to determine organ
dysfunction in diabetic and nondiabetic mice. The concen-
trations of serum ALT, AST, and ALP were not significantly
different between mice supplemented with vitamin D and
controls. Measuring serum urea and creatinine levels is an
alternative approach to estimate renal function [27]. In our
study, diabetic mice showed low albumin levels and high
serum levels of both creatinine and urea and a thickening of
the Bowman’s capsule compared to nondiabetic mice. These
results may indicate renal failure [4]. However, vitamin D
supplementation did not restore these renal parameters.
Alterations in hematological parameters are common
in diabetes patients [28]. Hyperglycemia-induced oxidative
stress in diabetic conditions leads to functional and mor-
phological alterations of the erythrocyte membrane [29].The
increased nonenzymatic glycosylation of RBC membrane
proteins and hyperglycemia could be responsible for the
low Hb levels in these patients [30]. Hyperglycemia and
oxidation of these proteins increase the production of lipid
peroxides that lead to hemolysis of RBC [31]. In our study,
diabetic mice had lower RBC counts and Hb and Htc levels
than controls. Conversely, vitamin D3-treated diabetic mice
showed RBC counts and Htc and Hb levels similar to those
of nondiabetic mice. These findings suggest that vitamin
D may affect erythropoiesis. Some studies have shown that
VDR is expressed in the bone marrow by specific cell subsets
such as stromal and accessory cells [32]. In addition, Aucella
et al. reported that patients with chronic kidney disease
undergoing hemodialysis showed a significant increase in Hb
8 BioMed Research International
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Figure 4: Liver tissue of mice. Photomicrograph of the mice liver tissue. C1, C2, and C3 liver tissue of animal control; CV1, CV2, and CV3
liver tissue of animal supplemented with vitamin D; D1, D2, and D3 liver tissue of diabetic animal; DV1, DV2, and DV3 liver tissue of diabetic
animal supplemented with vitamin D. Liver sinusoids (S). (Bars, C1, CV1, D1, and DV1 = 100𝜇m; C2, CV2, D2, and DV2 = 50 𝜇m; C3, CV3,
D3, and DV3 = 10𝜇m). Staining: H/E.
concentration and Htc level after four months of treatment
with vitamin D [33].
Increased WBC counts are common in acute and
chronic diabetes complications [34]. However Matough et al.
observed lowerWBC counts in diabetic mice as compared to
nondiabetic animals [30]. In our study, diabetic mice showed
lower mononuclear cell and WBC counts than control mice.
Conversely, vitamin D3 treatment restored mononuclear cell
andWBC counts on diabetic mice to levels similar to those of
nondiabetic mice. Interestingly, vitamin D3-treated diabetic
mice showed a reduction in pulmonary and peritoneal
leukocyte counts compared to diabetic animals. Some studies
have shown that VDR expression on leukocyte subsets [35]
could increase leukocytemigration from tissues to peripheral
blood.
Taken together, our results suggest that vitamin D sup-
plementation may improve hematological parameters and
reduce cell counts of BAL and PeL fluids during the course
of diabetes.
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